Le Lézard
Classified in: Health, Science and technology, Business
Subjects: FNC, PET, ANW

SOUTH DAKOTA COMPANY TO COMBAT CATTLE DISEASES SPREAD BY INVASIVE ASIAN LONGHORNED TICK


Medgene awarded USDA funding to leverage the company's platform technology against tickborne disease targets

BROOKINGS, S.D., May 22, 2023 /PRNewswire/ -- The USDA's National Institute of Food and Agriculture (NIFA) has awarded animal health company Medgene grant funding to study the Asian longhorned tick and its ability to spread diseases in animal livestock. The company will be using its proprietary platform technology to develop and test vaccine approaches to prevent the spread of diseases caused by the tick.

"Animal parasites and insects are major disease vectors that have significant impacts on wild animals and livestock."

Dr. Alan Young, Chief Technology Officer for Medgene, has been researching parasite borne diseases since 2013, studying the effects of tickborne diseases in whitetail deer. "Animal parasites and insects are major disease vectors that have significant impacts on wild animals and livestock. This partnership with USDA-NIFA shows the agency's awareness and dedication to addressing animal health concerns in the United States."

Medgene's vaccine approaches leverage a USDA-approved "platform technology" that is safely and easily adapted to multiple animal disease targets. The result is the development of vaccines and an understanding of how diseases move within species and geography within a fraction of the time of traditional vaccine approaches. 

Medgene received the award notice from USDA-NIFA in April and will begin field research this summer. The eight-month study will be conducted in conjunction with an independently-operated research facility and supported by an international team of recognized experts in tickborne diseases.

"I believe Medgene's research addresses an unmet need in an industry that is in desperate need of more effective methods to control ticks and tickborne diseases," stated Jose d la Fuente, PhD, Professor of Molecular Biology & Biotechnology at the University of Castillia - La Mancha in Ciudad Real, Spain.

Medgene will incorporate the results of this research into its current platform technology-based vaccine portfolio and ultimately apply these findings to other tickborne diseases, such as Lyme Disease and Rocky Mountain Spotted Fever.

SOURCE Medgene


These press releases may also interest you

at 22:30
Monsanto Wins Appeal Ruling in Erickson v. Monsanto
Today, a decision was issued by the Court of Appeals Division I in the State of Washington in Erickson v. Monsanto, ruling in Monsanto's favor on multiple grounds. This decision reverses the initial verdict of $185 million in its entirety and...

at 21:30
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc.  today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and Poseida have entered into a...

at 21:00
Memorial Regional Hospital Named Florida's First Resuscitation Center of Excellence
Memorial Regional Hospital in Florida has earned the prestigious title of being the state's inaugural Resuscitation Center of Excellence (RCOE), underscoring the hospital's adherence to over 30 evidence-based criteria in providing top-tier cardiac...

at 19:31
Momcozy Announces Collaboration with 1 Natural Way To Provide Accessible Breastfeeding Solutions For New Mothers
Momcozy, a trusted global brand specializing in solution-focused maternal and baby care products since 2018, has announced their collaboration with 1 Natural Way (1NW), a nationally recognized Durable Medical Equipment company catering to the precise...

at 19:01
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomicstm antigen discovery technologies to target five more cancers
Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today announced the completion of a...

at 17:49
The ALS Association Kicks Off ALS Awareness Month and Commemorates the 10th Anniversary of the Ice Bucket Challenge
The ALS Association today celebrated the beginning of ALS Awareness Month and the 10th Anniversary of the Ice Bucket Challenge, which inspired the world to join the fight against ALS in the summer of 2014. Throughout May and the summer, the ALS...

More news about Health...


News published on and distributed by: